Novabio ResearchGHK-Cu
Ordered GHK-Cu from Novabio Research? Mail in a sample (US only) and let us test it for free.
Test my supplyNovabio Research's Purity focus record is strongest in GHK-Cu, but that signal rests on a small set rather than a broad catalog pattern. The larger Retatrutide file is dominated by recent identity failures despite two isolated clean results, while Tirzepatide is also weak, leaving the evidence dispersed and uncertainty high outside GHK-Cu.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Novabio Research rows.
Cancel anytime
About Novabio Research test results from Finnrick
Novabio Research is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 39 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Novabio Research peptides in this dataset are Retatrutide (32 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 39 recent tests.
Ordered GHK-Cu from Novabio Research? Mail in a sample (US only) and let us test it for free.
Test my supply